Related Experiment Videos
[Percutaneous estrogen therapy in the post-menopausal period]
1Departement für Frauenheikunde, Universitätsspital Zürich.
Schweizerische Medizinische Wochenschrift
|July 22, 1989
Summary
Topical estradiol gel offers a safe and effective alternative for postmenopausal hormone therapy. This treatment significantly reduces climacteric symptoms and improves vaginal health with minimal side effects.
Area of Science:
- Endocrinology
- Gynecology
- Pharmacology
Background:
- Percutaneous estradiol offers a physiological alternative to oral estrogen replacement therapy.
- Transdermal administration bypasses the first liver pass, allowing for reduced dosing.
- A novel hydroalcoholic gel formulation of 17 beta-estradiol was developed.
Purpose of the Study:
- To investigate the efficacy and pharmacological effects of a new estradiol gel.
- To evaluate the impact on climacteric symptoms and vaginal health.
- To assess the effects on metabolic parameters and safety profile.
Main Methods:
- A clinical trial involving 114 postmenopausal women.
- Assessment of the Kuppermann index for climacteric symptoms.
- Evaluation of vaginal maturation index and lipid profiles.
- Monitoring of side effects and patient acceptability.
Main Results:
- Significant reduction in Kuppermann index scores within 3 months.
- Marked improvement in vaginal atrophy and maturation index.
- Favorable changes in lipid profile: decreased total cholesterol, triglycerides, LDL, and VLDL; unchanged HDL.
- Low incidence of side effects (breast tenderness, vaginal bleeding) and excellent acceptability.
Conclusions:
- The hydroalcoholic estradiol gel is effective in managing postmenopausal symptoms.
- It demonstrates a favorable safety and tolerability profile.
- This topical treatment presents an attractive option for clinical practice, potentially preventing bone loss.